Supplementary Figures 1, 2, 3 from Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients
Year: 2023
Type: supplementary-materials
Abstract: Sup Fig 1. Patient demographic data for clinical trials UPCI 08-013 and UPCI 06-120. Sup Fig 2.Flow cytometric plots from representative donor PBMC showing percentages of CD14+ and CD56+ Sup Fig 3. Flow cytometric histogram illustrating the relative EGFR expression
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361885697